LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 307 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1 | -99.9% | 17 | +30.8% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 13 | -13.3% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 15 | +7.1% | 0.00% | – |
Q3 2019 | $1,000 | -50.0% | 14 | -6.7% | 0.00% | – |
Q1 2019 | $2,000 | -99.8% | 15 | -99.8% | 0.00% | -100.0% |
Q4 2018 | $891,000 | -47.5% | 6,570 | +6.3% | 0.00% | -33.3% |
Q3 2018 | $1,696,000 | +36.4% | 6,179 | +3.0% | 0.01% | +20.0% |
Q2 2018 | $1,243,000 | +25.4% | 6,000 | 0.0% | 0.01% | +25.0% |
Q1 2018 | $991,000 | +16.7% | 6,000 | -3.2% | 0.00% | +33.3% |
Q4 2017 | $849,000 | +72.2% | 6,200 | +71.2% | 0.00% | +50.0% |
Q3 2017 | $493,000 | +16333.3% | 3,621 | +17142.9% | 0.00% | – |
Q2 2017 | $3,000 | +50.0% | 21 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | -75.0% | 21 | -73.1% | 0.00% | – |
Q4 2016 | $8,000 | -98.6% | 78 | -98.6% | 0.00% | -100.0% |
Q3 2016 | $565,000 | +5036.4% | 5,542 | +5990.1% | 0.00% | – |
Q2 2016 | $11,000 | -38.9% | 91 | -45.5% | 0.00% | – |
Q1 2016 | $18,000 | -99.2% | 167 | -99.2% | 0.00% | -100.0% |
Q4 2015 | $2,374,000 | +26.6% | 21,894 | 0.0% | 0.01% | +18.2% |
Q3 2015 | $1,875,000 | +37400.0% | 21,894 | +45512.5% | 0.01% | – |
Q2 2015 | $5,000 | +25.0% | 48 | 0.0% | 0.00% | – |
Q1 2015 | $4,000 | – | 48 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |